CUBIST PHARMACEUTICALS INC
CBST
CBST was delisted on the 21st of January, 2015.
276 hedge funds and large institutions have $7.35B invested in CUBIST PHARMACEUTICALS INC in 2013 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 100 increasing their positions, 111 reducing their positions, and 38 closing their positions.
190% more call options, than puts
Call options by funds: $198M | Put options by funds: $68.1M
19% more capital invested
Capital invested by funds: $6.18B → $7.35B (+$1.16B)
14% more funds holding in top 10
Funds holding in top 10: 7 → 8 (+1)
13% more first-time investments, than exits
New positions opened: 43 | Existing positions closed: 38
2% more funds holding
Funds holding: 271 → 276 (+5)
10% less repeat investments, than reductions
Existing positions increased: 100 | Existing positions reduced: 111
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$257M |
| 2 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$87.2M |
| 3 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
+$57.6M |
| 4 |
Westfield Capital Management
Boston,
Massachusetts
|
+$56.9M |
| 5 |
Barclays
London,
United Kingdom
|
+$40.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BNP Paribas Financial Markets
Paris,
France
|
-$609M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$76.4M |
| 3 |
O
OrbiMed
New York
|
-$52.7M |
| 4 |
Wells Fargo
San Francisco,
California
|
-$49.5M |
| 5 |
Millennium Management
New York
|
-$44.4M |
CBST Hedge Fund Activity: Q4 2013 in Review
276 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in CUBIST PHARMACEUTICALS INC (CBST) for Q4 2013, worth a combined $7.35B — up 19% from $6.18B a quarter earlier.
Buyers outnumbered sellers: 43 funds opened new CBST positions and 38 closed out — a net gain of 5 holders — while 100 added to existing stakes and 111 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $257M. The largest seller was BNP Paribas Financial Markets, cutting an estimated $609M.
- 276 institutional investors held CUBIST PHARMACEUTICALS INC (CBST) as of Q4 2013, up from 271 in Q3 2013.
- Funds reported $7.35B of CUBIST PHARMACEUTICALS INC stock for Q4 2013, up 19% quarter-over-quarter.
- 43 funds opened new CUBIST PHARMACEUTICALS INC positions in Q4 2013 and 38 closed out, a net change of +5 holders.
- The largest CUBIST PHARMACEUTICALS INC buyer in Q4 2013 was Fidelity Investments, an estimated $257M added.
- The largest CUBIST PHARMACEUTICALS INC seller in Q4 2013 was BNP Paribas Financial Markets, an estimated $609M sold.
Based on aggregated 13F filings for Q4 2013.